X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2167) 2167
Publication (113) 113
Newsletter (43) 43
Book Chapter (20) 20
Book Review (13) 13
Conference Proceeding (2) 2
Book / eBook (1) 1
Dissertation (1) 1
Magazine Article (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1764) 1764
female (1097) 1097
thrombocytosis (1084) 1084
male (977) 977
middle aged (793) 793
adult (704) 704
index medicus (673) 673
aged (636) 636
hematology (575) 575
platelet count (457) 457
oncology (433) 433
thrombocytosis - drug therapy (332) 332
thrombocytosis - complications (324) 324
thrombocytosis - etiology (313) 313
prognosis (308) 308
retrospective studies (243) 243
aged, 80 and over (230) 230
thrombocythemia (226) 226
polycythemia-vera (225) 225
essential thrombocythemia (220) 220
risk factors (215) 215
thrombocytosis - blood (214) 214
thrombocytosis - diagnosis (209) 209
thrombosis (207) 207
platelets (196) 196
cancer (188) 188
diagnosis (187) 187
thrombocytosis - therapy (184) 184
adolescent (177) 177
care and treatment (177) 177
survival (176) 176
blood platelets (167) 167
myeloproliferative disorders (158) 158
treatment outcome (157) 157
mutation (155) 155
medicine, general & internal (147) 147
research (147) 147
child (146) 146
surgery (144) 144
analysis (134) 134
myelofibrosis (132) 132
animals (130) 130
therapy (128) 128
medicine & public health (125) 125
leukemia (123) 123
anemia (119) 119
hydroxyurea (115) 115
diagnosis, differential (113) 113
polycythemia vera (113) 113
metastasis (112) 112
patients (112) 112
follow-up studies (108) 108
thrombocytosis - chemically induced (107) 107
hydroxyurea - therapeutic use (105) 105
pediatrics (105) 105
child, preschool (102) 102
thrombocytosis - pathology (102) 102
blood (101) 101
disease (99) 99
thrombocytosis - genetics (99) 99
thrombopoietin (96) 96
janus kinase 2 - genetics (93) 93
blood cell count (92) 92
health aspects (92) 92
platelet aggregation inhibitors - therapeutic use (92) 92
tumors (92) 92
risk (88) 88
drug therapy (85) 85
aspirin - therapeutic use (84) 84
splenectomy (84) 84
infant (82) 82
time factors (82) 82
carcinoma (79) 79
reactive thrombocytosis (78) 78
inflammation (76) 76
pregnancy (76) 76
myeloproliferative neoplasms (75) 75
antineoplastic agents - therapeutic use (74) 74
prospective studies (74) 74
chemotherapy (73) 73
multivariate analysis (72) 72
abridged index medicus (71) 71
medicine (71) 71
thrombosis - etiology (71) 71
young adult (70) 70
quinazolines - therapeutic use (68) 68
essential thrombocytosis (67) 67
genetic aspects (67) 67
aspirin (66) 66
bone marrow - pathology (66) 66
myeloproliferative disorders - complications (66) 66
polycythemia vera - drug therapy (66) 66
thrombocythemia, essential - drug therapy (66) 66
anagrelide (65) 65
thrombocythemia, essential - diagnosis (65) 65
leukocyte count (64) 64
medical prognosis (64) 64
survival analysis (64) 64
complications and side effects (63) 63
interferon-alpha - therapeutic use (63) 63
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2032) 2032
French (45) 45
German (42) 42
Japanese (28) 28
Spanish (16) 16
Russian (12) 12
Polish (11) 11
Danish (8) 8
Italian (8) 8
Dutch (7) 7
Chinese (5) 5
Czech (5) 5
Finnish (3) 3
Hebrew (3) 3
Korean (2) 2
Arabic (1) 1
Portuguese (1) 1
Serbian (1) 1
Slovak (1) 1
Slovenian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JOURNAL OF NUCLEAR MEDICINE, ISSN 0161-5505, 02/2017, Volume 58, Issue 2, pp. 312 - 319
Radioligand therapy (RLT) with Lu-177-PSMA-617 (PSMA is prostate specific membrane antigen) is a novel targeted therapy for metastatic prostate cancer. In this... 
SURVIVAL | PRETREATMENT THROMBOCYTOSIS | NEUROENDOCRINE TUMORS | MEMBRANE ANTIGEN | PROGNOSTIC VALUE | CHEMOTHERAPY | PSMA | prostate cancer | GYNECOLOGIC MALIGNANCIES | PREDNISONE | treatment response | RADIONUCLIDE THERAPY | SOMATOSTATIN | radioligand therapy | Lu-177 | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PSA
Journal Article
Journal Article
Cancer, ISSN 0008-543X, 08/2007, Volume 110, Issue 3, pp. 543 - 550
BACKGROUND. Therapy targeted against the vascular endothelial growth factor (VEGF) pathway is a standard of care for patients with metastatic renal cell... 
prognostic factors | prognostic model | advanced renal cell carcinoma | vascular endothelial growth factor | angiogenesis | Angiogenesis | Prognostic model | Vascular endothelial growth factor | Advanced renal cell carcinoma | Prognostic factors | PROGNOSTIC-FACTORS | LONG-TERM SURVIVAL | TUMOR-SUPPRESSOR GENE | CANCER | INTERFERON-ALPHA | ONCOLOGY | PLATELETS | DISEASE | SUNITINIB | THROMBOCYTOSIS | PROGRESSION | Niacinamide - analogs & derivatives | Prognosis | Prospective Studies | Humans | Middle Aged | Neovascularization, Pathologic | Imidazoles - administration & dosage | Male | Kidney Neoplasms - metabolism | Phenylurea Compounds | Vascular Endothelial Growth Factor A - metabolism | Benzenesulfonates - administration & dosage | Indazoles - administration & dosage | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Indoles - administration & dosage | Bevacizumab | Antibodies, Monoclonal, Humanized | Clinical Trials, Phase III as Topic | Pyrroles - administration & dosage | Female | Carcinoma, Renal Cell - drug therapy | Pyridines - administration & dosage | Carcinoma, Renal Cell - pathology | Survival Rate | Vascular Endothelial Growth Factor A - immunology | Randomized Controlled Trials as Topic | Carcinoma, Renal Cell - metabolism | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Kidney Neoplasms - pathology | Kidney Neoplasms - drug therapy | Clinical Trials, Phase II as Topic | Patient outcomes | Physiological aspects | Carcinoma, Renal cell | Diagnosis | Research | Metastasis | Neovascularization | Drug therapy
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2012, Volume 7, Issue 4, p. e34520
Background and Aims: Secondary thrombocytosis is a clinical feature of unknown significance. In inflammatory bowel disease (IBD), thrombocytosis is considered... 
DEFICIENCY ANEMIA | ERYTHROPOIETIN | PORTAL-VEIN THROMBOSIS | CROHNS-DISEASE | ULCERATIVE-COLITIS | INTRAVENOUS IRON | BIOLOGY | THROMBOEMBOLIC EVENTS | RANDOMIZED CONTROLLED-TRIAL | FERRIC CARBOXYMALTOSE | THROMBOCYTOSIS | Anemia, Iron-Deficiency - drug therapy | Prospective Studies | Erythropoietin - therapeutic use | Humans | Inflammatory Bowel Diseases - metabolism | Anemia, Iron-Deficiency - blood | Thrombocytosis - blood | C-Reactive Protein - metabolism | Ferritins - metabolism | Blood Platelets - cytology | Iron - deficiency | Thrombocytosis - metabolism | Iron Compounds - therapeutic use | Leukocyte Count | Blood Platelets - drug effects | Inflammatory Bowel Diseases - complications | Inflammatory Bowel Diseases - drug therapy | Hemoglobins - metabolism | Inflammatory Bowel Diseases - blood | Platelet Count - methods | Thrombocytosis - drug therapy | Iron - therapeutic use | Blood Platelets - metabolism | Transferrin - metabolism | Anemia, Iron-Deficiency - metabolism | Cohort Studies | Medical research | Care and treatment | C-reactive protein | Erythropoietin | Anemia | Analysis | Gastrointestinal diseases | Ferritin | Hemoglobin | Medicine, Experimental | Iron sulfates | Therapy | Transferrin | Inflammatory bowel diseases | Sucrose | Laboratories | Clinical trials | Iron | Subgroups | Intestine | Thrombocytosis | Standard deviation | Colon | Thromboembolism | Drug dosages | Sugars | Chronic illnesses | Nutrient deficiency | Patients | Thrombosis | Inflammatory bowel disease | White blood cells | Medicine | Platelets | Cancer
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2006, Volume 1, Issue 1, p. e18
Background. A somatic activating mutation (V617F) in the JAK2 tyrosine kinase was recently discovered in the majority of patients with polycythemia vera (PV),... 
BIOLOGY | Erythropoiesis | Humans | Polycythemia Vera - blood | Polycythemia Vera - genetics | Primary Myelofibrosis - pathology | Janus Kinase 2 - metabolism | Bone Marrow Transplantation | Janus Kinase 2 - antagonists & inhibitors | Disease Models, Animal | Recombinant Proteins - metabolism | Transduction, Genetic | Mice, Inbred C57BL | Janus Kinase 2 - genetics | Primary Myelofibrosis - etiology | Polycythemia Vera - enzymology | Leukocytosis - etiology | Recombinant Proteins - genetics | Mice, Knockout | Point Mutation | Animals | Platelet Count | Protein Kinase Inhibitors - therapeutic use | Polycythemia Vera - drug therapy | Mice | Mice, Inbred BALB C | Enzyme Activation | Leukocytosis - blood | Amino Acid Substitution | Tyrosine | Erythropoietin | Polycythemia | Bone marrow | Hemoglobin | Transplantation | Therapy | Splenomegaly | Laboratories | Syngeneic grafts | Pathogenesis | Leukemia | Hematocrit | Bone marrow transplantation | Oncology | Polycythemia vera | Kinases | Bleeding | Signal transduction | Granulocytes | Janus kinase 2 | Thrombocytosis | Inbreeding | Megakaryocytes | Protein-tyrosine kinase | Hck protein | Spleen | Imatinib | Myelofibrosis | Complications | Colonies | Abnormalities | Patients | Thrombosis | Hemopoiesis | Leukocytosis | Inhibitors | Fibrosis | Neutrophilia | Mutation | Hematopoietic system | Platelets | Cancer
Journal Article
CANCER, ISSN 0008-543X, 06/2006, Volume 106, Issue 11, pp. 2397 - 2405
Journal Article
Annals of Hematology, ISSN 0939-5555, 12/2010, Volume 89, Issue 12, pp. 1233 - 1237
Journal Article
Platelets, ISSN 0953-7104, 10/2018, Volume 29, Issue 7, pp. 644 - 649
A variety of laboratory tests have been developed, which can diagnose a number of both congenital and acquired disorders of platelet function. Many tests of... 
thrombocytosis | Antiplatelet drugs | thrombocytopenia | platelet aggregation | POLYCYTHEMIA-VERA | ACTIVATION | MYELOPROLIFERATIVE DISORDERS | PROGNOSTIC-FACTORS | PLATELET-FUNCTION | THROMBOXANE BIOSYNTHESIS | CLOPIDOGREL-TREATED PATIENTS | CELL BIOLOGY | PERCUTANEOUS CORONARY INTERVENTION | LIGHT TRANSMISSION AGGREGOMETRY | HEMATOLOGY | AGGREGATION
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 11/2013, Volume 19, Issue 22, pp. 6230 - 6241
Journal Article